DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
TargeGen closes on $40 million venture round
News | 07. 12. 2007
TargeGen
TargeGen, Inc. has announced that the Company has successfully closed a $40M venture round of financing.
